Monoamine oxidase. I. Specificity of some substrates and inhibitors.
D000588:Amines / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D001921:Brain / Q000166:cytology / Q000201:enzymology; D003514:Cyclohexylamines / Q000494:pharmacology; D005461:Fluorine / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007700:Kinetics; D008928:Mitochondria / Q000201:enzymology; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D010084:Oxidation-Reduction; D010091:Oximes / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010654:Phenylbutyrates / Q000494:pharmacology; D010665:Phenylpropanolamine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011199:Potentiometry; D013552:Swine; D014439:Tyramine / Q000494:pharmacology
D000588:Amines; D001593:Benzyl Compounds; D003514:Cyclohexylamines; D008996:Monoamine Oxidase Inhibitors; D009419:Nerve Tissue Proteins; D010091:Oximes; D010627:Phenethylamines; D010654:Phenylbutyrates; D010880:Piperidines; D005461:Fluorine; D010665:Phenylpropanolamine; D000661:Amphetamine; D008995:Monoamine Oxidase; D014439:Tyramine